New Drug Class Promising Against Breast Cancer with BRCA Mutations

An experimental drug called olaparib shows promise for women with breast cancer who carry BRCA1 and BRCA2 gene mutations.

Oncologists Issue New Guidelines Regarding Hormonal Therapy

The ASCO recently announced that adding an aromatase inhibitor during breast cancer treatment results in a lower risk of recurrence.

Fish Oil Linked to Lower Breast Cancer Risk

Women who regularly take fish oil supplements may find they have been protecting themselves against breast cancer as well.